TAVI: Japan Approves Medtronic's CoreValve
Monday, March 30, 2015
Source: Mass Device
Medtronic (NYSE:MDT) today said it won approval in Japan for its CoreValve replacement heart valve.
Fridley, Minn.-based Medtronic said the approval covers patients with severe aortic stenosis who are too sick to go through open heart surgery.